Recursion PharmaceuticalsRXRX
那斯達克 · USD
3.25
-0.20
(-5.80%)
盤中 03/13 12:47 (UTC+8)
03/13 12:47 (UTC+8)
Recursion PharmaceuticalsRXRX
3.25
-0.20
(-5.80%)
財務數據
損益表
- 0.11
- 0.11
- 0.14
- 0.14
- 0.26
- 0.05
- 0.15
- 0.19
- 0.05
- 0.35
- -4.39
- 3.40
- 26.66
- 4.52
- 80.91
- -82.57
- 224.35
- 30.37
- -73.08
- 583.11
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 35,351 | 5,175 | 19,223 | 14,745 | 4,546 | 26,082 | 14,417 | 13,794 | 10,891 | 10,533 |
營業成本 | 14,275 | 14,688 | 20,161 | 21,829 | 12,794 | 12,079 | 9,199 | 11,166 | 9,881 | 10,877 |
營業毛利 | 21,263 | -9,513 | -938 | -7,084 | -8,248 | 14,003 | 5,218 | 2,628 | 1,010 | -344 |
營業費用 | 129,597 | 162,690 | 175,289 | 184,284 | 175,520 | - | - | 98,968 | 99,940 | 99,206 |
研發費用 | 95,940 | 121,062 | 128,635 | 129,634 | 98,334 | 74,599 | 73,928 | 67,560 | 69,482 | 70,007 |
推銷及管理費用 | 33,657 | 41,628 | 46,654 | 54,650 | 77,186 | 37,757 | 31,833 | 31,408 | 30,458 | 29,199 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -108,334 | -172,203 | -176,227 | -191,368 | -183,768 | -98,353 | -100,543 | -96,340 | -98,930 | -99,550 |
其他收入及費用 | 232 | 9,952 | 4,330 | -11,277 | 4,869 | 2,679 | 2,480 | 4,188 | 1,872 | 6,533 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -108,101 | -162,251 | -171,897 | -202,645 | -178,899 | -95,674 | -98,063 | -92,152 | -97,058 | -93,017 |
所得稅 | 20 | 2 | - | -158 | 7 | 168 | -523 | -779 | -4,062 | - |
稅後純益 | -108,122 | -162,253 | -171,897 | -202,487 | -178,906 | -95,842 | -97,540 | -91,373 | -92,996 | -93,017 |
基本每股稅後盈餘(元) | -0.17 | -0.36 | -0.41 | -0.50 | -0.53 | -0.34 | -0.40 | -0.39 | -0.42 | -0.43 |
稀釋每股稅後盈餘(元) | -0.17 | -0.36 | -0.41 | -0.50 | -0.57 | -0.33 | -0.40 | -0.39 | -0.42 | -0.45 |
基本平均股數(千股) | 522664.00 | 446988.00 | 417361.00 | 402771.00 | 336035.00 | 282583.00 | 242196.00 | 236019.00 | 223158.00 | 214327.00 |
稀釋平均股數(千股) | 522664.00 | 446988.00 | 417361.00 | 402771.00 | 336035.00 | 282583.00 | 242196.00 | 236019.00 | 223158.00 | 214327.00 |
還原基本每股稅後盈餘(元) | -0.17 | -0.36 | -0.41 | -0.50 | -0.53 | -0.34 | -0.40 | -0.39 | -0.42 | -0.43 |
還原稀釋每股稅後盈餘(元) | -0.17 | -0.36 | -0.41 | -0.50 | -0.57 | -0.33 | -0.40 | -0.39 | -0.42 | -0.45 |
還原基本平均股數(千股) | 522,664 | 446,988 | 417,361 | 402,771 | 336,035 | 282,583 | 242,196 | 236,019 | 223,158 | 214,327 |
還原稀釋平均股數(千股) | 522,664 | 446,988 | 417,361 | 402,771 | 336,035 | 282,583 | 242,196 | 236,019 | 223,158 | 214,327 |
EBITDA(千元) | -88,624 | -141,208 | -148,048 | -183,314 | -165,948 | -88,476 | -89,095 | -84,775 | -89,505 | -85,439 |